We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)
We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)
Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function
Updated: 4/1/2016
Modifiable Effectors of Renin System Activation: Treatment Evaluation (MODERATE)
Status: Enrolling
Updated: 4/1/2016
Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function
Updated: 4/1/2016
Modifiable Effectors of Renin System Activation: Treatment Evaluation (MODERATE)
Status: Enrolling
Updated: 4/1/2016
Click here to add this to my saved trials
A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.
Updated: 4/5/2016
A Multicenter, Group Study to Evaluate the Safety and Efficacy of Amlodipine and Benazepril Administered in Combination Compared to Amlodipine Monotherapy in Hypertensive Patients Not Adequately Controlled With Amlodipine Alone
Status: Enrolling
Updated: 4/5/2016
A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.
Updated: 4/5/2016
A Multicenter, Group Study to Evaluate the Safety and Efficacy of Amlodipine and Benazepril Administered in Combination Compared to Amlodipine Monotherapy in Hypertensive Patients Not Adequately Controlled With Amlodipine Alone
Status: Enrolling
Updated: 4/5/2016
Click here to add this to my saved trials
Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence
Updated: 4/6/2016
Hypertension Control and Therapy Adherence
Status: Enrolling
Updated: 4/6/2016
Clinician Counseling and Cultural Competency to Improve Hypertension Control and Therapy Adherence
Updated: 4/6/2016
Hypertension Control and Therapy Adherence
Status: Enrolling
Updated: 4/6/2016
Click here to add this to my saved trials
Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults
Updated: 4/15/2016
Trace Elements and CVD Risk Factors Among Young Adults
Status: Enrolling
Updated: 4/15/2016
Examining the Link Between Trace Elements and Cardiovascular Disease Risk Factors in Young Adults
Updated: 4/15/2016
Trace Elements and CVD Risk Factors Among Young Adults
Status: Enrolling
Updated: 4/15/2016
Click here to add this to my saved trials
Relaxation Response Training to Treat Hypertension
Updated: 4/18/2016
Relaxation Response Training to Treat Hypertension: Effects on Blood Pressure, Biomarkers, and Endothelial Function
Status: Enrolling
Updated: 4/18/2016
Relaxation Response Training to Treat Hypertension
Updated: 4/18/2016
Relaxation Response Training to Treat Hypertension: Effects on Blood Pressure, Biomarkers, and Endothelial Function
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585
Updated: 4/20/2016
A Randomized, Double-blind, Placebo-controlled, Phase 1, First-in-human, Single-center, Safety, Tolerability, Ventricular Repolarization and Pharmacokinetic Study of Single and Multiple Ascending Doses of KAR5585 in Healthy Subjects
Status: Enrolling
Updated: 4/20/2016
Single and Multiple Ascending Doses Clinical Pharmacology Study With KAR5585
Updated: 4/20/2016
A Randomized, Double-blind, Placebo-controlled, Phase 1, First-in-human, Single-center, Safety, Tolerability, Ventricular Repolarization and Pharmacokinetic Study of Single and Multiple Ascending Doses of KAR5585 in Healthy Subjects
Status: Enrolling
Updated: 4/20/2016
Click here to add this to my saved trials
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Updated: 4/26/2016
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Updated: 4/26/2016
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
Click here to add this to my saved trials
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Updated: 4/26/2016
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Updated: 4/26/2016
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
Click here to add this to my saved trials
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Updated: 4/26/2016
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Updated: 4/26/2016
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
Click here to add this to my saved trials
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Updated: 4/26/2016
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Updated: 4/26/2016
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
Click here to add this to my saved trials
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Updated: 4/26/2016
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Updated: 4/26/2016
A Randomized, Observer-masked Study of the Safety, Tolerability and Pharmacodynamics of Sequential Ascending 28-Day Repeated Topical Doses of SAR366234 Versus Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 4/26/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
Updated: 5/2/2016
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Updated: 5/2/2016
Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel-group, 24-week Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Updated: 5/2/2016
Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel-group, 24-week Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Updated: 5/2/2016
Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel-group, 24-week Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Updated: 5/2/2016
Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel-group, 24-week Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Updated: 5/2/2016
Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel-group, 24-week Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Updated: 5/2/2016
Prospective, Randomized, Placebo-controlled, Double-blind, Multicenter, Parallel-group, 24-week Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Physiological Effects of Grape Seed Extract in Diastolic Heart Failure
Updated: 5/10/2016
GRAPe Seed Extract and Ventriculovascular Investigation in Normal Ejection-Fraction Heart Failure
Status: Enrolling
Updated: 5/10/2016
Physiological Effects of Grape Seed Extract in Diastolic Heart Failure
Updated: 5/10/2016
GRAPe Seed Extract and Ventriculovascular Investigation in Normal Ejection-Fraction Heart Failure
Status: Enrolling
Updated: 5/10/2016
Click here to add this to my saved trials
Bosentan in Children With Pulmonary Arterial Hypertension
Updated: 5/23/2016
An Open Label, Multicenter Study to Assess the Pharmacokinetics, Tolerability, and Safety of a Pediatric Formulation of Bosentan in Children With Idiopathic or Familial Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/23/2016
Bosentan in Children With Pulmonary Arterial Hypertension
Updated: 5/23/2016
An Open Label, Multicenter Study to Assess the Pharmacokinetics, Tolerability, and Safety of a Pediatric Formulation of Bosentan in Children With Idiopathic or Familial Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Bosentan in Children With Pulmonary Arterial Hypertension
Updated: 5/23/2016
An Open Label, Multicenter Study to Assess the Pharmacokinetics, Tolerability, and Safety of a Pediatric Formulation of Bosentan in Children With Idiopathic or Familial Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/23/2016
Bosentan in Children With Pulmonary Arterial Hypertension
Updated: 5/23/2016
An Open Label, Multicenter Study to Assess the Pharmacokinetics, Tolerability, and Safety of a Pediatric Formulation of Bosentan in Children With Idiopathic or Familial Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Bosentan in Children With Pulmonary Arterial Hypertension
Updated: 5/23/2016
An Open Label, Multicenter Study to Assess the Pharmacokinetics, Tolerability, and Safety of a Pediatric Formulation of Bosentan in Children With Idiopathic or Familial Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/23/2016
Bosentan in Children With Pulmonary Arterial Hypertension
Updated: 5/23/2016
An Open Label, Multicenter Study to Assess the Pharmacokinetics, Tolerability, and Safety of a Pediatric Formulation of Bosentan in Children With Idiopathic or Familial Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
Updated: 5/25/2016
A Pharmacokinetic Substudy of Subjects Transitioning From Twice Daily to Three Times Daily Dosing of UT-15 SR (Treprostinil Diethanolamine) in the TDE-PH-304 Protocol
Status: Enrolling
Updated: 5/25/2016
A Pharmacokinetic Substudy of the TDE-PH-304 Protocol
Updated: 5/25/2016
A Pharmacokinetic Substudy of Subjects Transitioning From Twice Daily to Three Times Daily Dosing of UT-15 SR (Treprostinil Diethanolamine) in the TDE-PH-304 Protocol
Status: Enrolling
Updated: 5/25/2016
Click here to add this to my saved trials
Interactive Multirisk-Factor Intervention for Hypertension (HTN) Blacks
Updated: 6/15/2016
Interactive Multirisk-Factor Intervention for HTN Blacks
Status: Enrolling
Updated: 6/15/2016
Interactive Multirisk-Factor Intervention for Hypertension (HTN) Blacks
Updated: 6/15/2016
Interactive Multirisk-Factor Intervention for HTN Blacks
Status: Enrolling
Updated: 6/15/2016
Click here to add this to my saved trials
Self-Management in Stroke Survivors
Updated: 6/23/2016
Promoting Self-Management in Stroke Survivors Using Health IT
Status: Enrolling
Updated: 6/23/2016
Self-Management in Stroke Survivors
Updated: 6/23/2016
Promoting Self-Management in Stroke Survivors Using Health IT
Status: Enrolling
Updated: 6/23/2016
Click here to add this to my saved trials
Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth
Updated: 7/11/2016
Impact of LifeSkills Training on Blood Pressure in Youth
Status: Enrolling
Updated: 7/11/2016
Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth
Updated: 7/11/2016
Impact of LifeSkills Training on Blood Pressure in Youth
Status: Enrolling
Updated: 7/11/2016
Click here to add this to my saved trials
Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth
Updated: 7/11/2016
Impact of LifeSkills Training on Blood Pressure in Youth
Status: Enrolling
Updated: 7/11/2016
Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth
Updated: 7/11/2016
Impact of LifeSkills Training on Blood Pressure in Youth
Status: Enrolling
Updated: 7/11/2016
Click here to add this to my saved trials
Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth
Updated: 7/11/2016
Impact of LifeSkills Training on Blood Pressure in Youth
Status: Enrolling
Updated: 7/11/2016
Effectiveness of an Anger and Stress Management Program on Reducing Blood Pressure Levels in Youth
Updated: 7/11/2016
Impact of LifeSkills Training on Blood Pressure in Youth
Status: Enrolling
Updated: 7/11/2016
Click here to add this to my saved trials
Improving Health Outcomes: Blood Pressure
Updated: 7/12/2016
Improving Health Outcomes: Blood Pressure Program in Practice Sites Located in the Chicago Metropolitan Area and in Maryland
Status: Enrolling
Updated: 7/12/2016
Improving Health Outcomes: Blood Pressure
Updated: 7/12/2016
Improving Health Outcomes: Blood Pressure Program in Practice Sites Located in the Chicago Metropolitan Area and in Maryland
Status: Enrolling
Updated: 7/12/2016
Click here to add this to my saved trials